MarginsXMarginsX
Home › Markets › Health Care › ASPE

Aspen Neuroscience Inc. (ASPE)

ASPE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$12.23
-2.86% on the day
Market cap
$355.6M
Small cap
Revenue
No annual revenue in SEC XBRL data for this filer
Net income
No annual revenue in SEC XBRL data for this filer

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerASPE on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2026
SEC CIK0002124080
SEC industry codePharmaceutical Preparations (SEC code, stale: periodic reports ended never filed)
Incorporated inDE

Financials

No annual revenue in SEC XBRL data for this filer.

Warning signs

Cash runway
no XBRL financials
Share count, 1 year
No year-earlier count
Going-concern doubt
No recent 10-K, 10-Q or 20-F
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo recent periodic reportNone on EDGAR
Cash and burnno XBRL financialsNone on EDGAR
Shares outstandingNo cover-page share count in XBRLNone on EDGAR
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, San Diego, California, United StatesPCAOB Form AP 2026-11-04
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
SEC reportingThe company has never filed a periodic report with the SEC, so its SEC industry code was never reviewed against one.None on EDGAR

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42026-10-30
Latest current report8-K2026-11-02

Source: SEC EDGAR submissions feed, 39 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.2%
1 monthNot enough price history
3 monthsNot enough price history
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high-15.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
SPRYARS Pharmaceuticals Inc.$3.59-7.71%$360.9M
RZLTRezolute Inc. Common Stock (NV)$3.58-2.05%$346.3M
PBYIPuma Biotechnology Inc$7.34-5.53%$379.5M
CTNMContineum Therapeutics Inc.$9.67-1.93%$379.7M
AVIRAtea Pharmaceuticals Inc.$4.12-4.19%$330.9M
CRMDCorMedix Inc.$4.82+3.43%$383.4M
RLMDRelmada Therapeutics Inc.$3.61-14.25%$385.2M
IRDOpus Genetics Inc.$4.04+1.51%$390.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier